Condition

Relapsed Adult AML clinical trials and research

• 8Clinical trials
• 8Countries

Newest Relapsed Adult AML clinical trials

All recruiting trials (8)

• Adapt NK cells for high-risk AML bridging to stem cell transplant

  This study tests an allogeneic NK cell infusion with a brief IL-2 boost in adults with relapsed or refractory AML to see if treatment can help prepare for a future stem cell transplant.

  Recruiting Phase 1/2 Masonic Cancer Center, University of Minnesota · Minneapolis, Minnesota · NCT07591649

• CD19 CAR-T therapy for adults with relapsed CD19-positive AML

  This will try CD19-directed CAR-T cell therapy in adults with relapsed or refractory AML whose leukemia cells express CD19.

  Recruiting Phase 1 University Hospital, Lille · Lille · NCT06649227

• Oral PCLX-001 for relapsed acute myeloid leukemia

  This study is testing if a new oral medication called PCLX-001 can safely help people with relapsed acute myeloid leukemia feel better.

  Recruiting Phase 1 Pacylex Pharmaceuticals · Houston, Texas · NCT06613217

• Using CLL-1 CAR NK cells to treat relapsed or refractory acute myeloid leukemia

  This study is testing a new type of immune cell treatment for people with relapsed or hard-to-treat acute myeloid leukemia to see if it helps them feel better.

  Recruiting Phase 1 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT06307054

• Combining oral azacitidine with gilteritinib for treating relapsed FLT3-mutated acute myeloid leukemia

  This study is testing if adding an oral medication called azacitidine to gilteritinib can help adults with relapsed FLT3-mutated acute myeloid leukemia feel better and live longer.

  Recruiting at 3 sites Phase 2 French Innovative Leukemia Organisation · Amiens and 19 other locations · NCT06022003

• Combining Venetoclax, Chidamide, and Azacitidine for treating relapsed AML

  This study is testing a new combination of three drugs to see if it can help people with relapsed acute myeloid leukemia feel better and achieve longer-lasting results.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT05305859

• Comparing two types of palliative care for patients with acute myeloid leukemia

  This study is testing if regular palliative care can help hospitalized patients with acute myeloid leukemia feel better and cope with their illness just as well as specialty palliative care.

  Recruiting at 20 sites Massachusetts General Hospital · Birmingham, Alabama and 19 other locations · NCT05237258

• Evaluating the safety and effectiveness of tuspetinib in patients with relapsed or refractory acute myeloid leukemia

  This study is testing a new drug called tuspetinib to see if it can safely help people with relapsed or hard-to-treat types of leukemia and related blood disorders.

  Recruiting at 10 sites Phase 1/2 Aptose Biosciences Inc. · Birmingham, Alabama and 33 other locations · NCT03850574

Related topics

Quick answers

How many Relapsed Adult AML clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 8 countries. The most sites are in United States (4 trials), China (2 trials), France (2 trials), Australia (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 3, Phase 2: 2, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →